We are live on ! Find out more
SC

Stralem & Co Portfolio holdings

AUM $157M
1-Year Est. Return 4.29%
This Fund
S&P 500
This Quarter Est. Return
+8.45%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
–
AUM
$988M
AUM Growth
-$217M
Cap. Flow
-$308M
Cap. Flow %
-31.17%
Top 10 Hldgs %
32.39%
Holding
60
New
5
Increased
1
Reduced
36
Closed
5

Top Buys

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$29.5M
2
CB icon
Chubb
CB
+$27.1M
3
MDLZ icon
Mondelez International
MDLZ
+$24.6M
4
LLY icon
Eli Lilly
LLY
+$1.39M
5
COST icon
Costco
COST
+$996K

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$31.8M
2
WBD icon
Warner Bros
WBD
+$31.8M
3
SBUX icon
Starbucks
SBUX
+$14M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$13.9M
5
MSFT icon
Microsoft
MSFT
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 26.49%
2 Consumer Staples 9.73%
3 Utilities 9.46%
4 Energy 9.28%
5 Financials 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVX icon
26
Chevron
CVX
$386B
$23.6M 2.39%
262,779
-85,883
-25% -$7.74M
SLB icon
27
SLB Ltd
SLB
$78.1B
$23.5M 2.38%
336,650
-102,850
-23% -$7.7M
ORCL icon
28
Oracle
ORCL
$442B
$23.5M 2.37%
642,091
-201,200
-24% -$7.68M
XOM icon
29
ExxonMobil
XOM
$657B
$22.9M 2.32%
294,005
-97,190
-25% -$7.77M
TMO icon
30
Thermo Fisher Scientific
TMO
$223B
$21.7M 2.19%
152,714
-53,900
-26% -$7.19M
EOG icon
31
EOG Resources
EOG
$75.1B
$21.6M 2.19%
305,283
-36,100
-11% -$2.93M
AMGN icon
32
Amgen
AMGN
$225B
$21.1M 2.14%
130,293
-41,075
-24% -$6.46M
CELG
33
DELISTED
Celgene Corp
CELG
$21M 2.12%
175,014
-54,100
-24% -$6.26M
ABT icon
34
Abbott
ABT
$192B
$20.5M 2.08%
456,607
-135,050
-23% -$5.96M
JNJ icon
35
Johnson & Johnson
JNJ
$629B
$19.5M 1.98%
190,266
-66,550
-26% -$6.69M
BMY icon
36
Bristol-Myers Squibb
BMY
$130B
$4.92M 0.5%
71,500
-4,400
-6% -$291K
ADP icon
37
Automatic Data Processing
ADP
$107B
$1.88M 0.19%
22,150
– –
KHC icon
38
Kraft Heinz
KHC
$29.1B
$1.8M 0.18%
24,800
– –
FE icon
39
FirstEnergy
FE
$27.2B
$1.54M 0.16%
48,400
– –
LLY icon
40
Eli Lilly
LLY
$1.09T
$1.41M 0.14%
+16,700
New +$1.39M
A icon
41
Agilent Technologies
A
$41.9B
$1.2M 0.12%
28,800
– –
IFF icon
42
International Flavors & Fragrances
IFF
$21.4B
$1.15M 0.12%
9,600
– –
CL icon
43
Colgate-Palmolive
CL
$73.6B
$1.13M 0.11%
17,000
– –
COST icon
44
Costco
COST
$421B
$1.02M 0.1%
+6,300
New +$996K
BRK.B icon
45
Berkshire Hathaway Class B
BRK.B
$1.09T
$990K 0.1%
7,500
– –
ZBH icon
46
Zimmer Biomet
ZBH
$18.7B
$959K 0.1%
9,631
– –
GILD icon
47
Gilead Sciences
GILD
$168B
$840K 0.09%
8,300
– –
SO icon
48
Southern Company
SO
$106B
$758K 0.08%
16,200
-4,000
-20% -$181K
AAPL icon
49
Apple
AAPL
$4.41T
$737K 0.07%
+28,000
New +$800K
RTX icon
50
RTX Corp
RTX
$300B
$682K 0.07%
11,282
-525,460
-98% -$31.8M
1
2
3

Similar funds

LI
Leap Investments Chicago, Illinois $152M AUM 3.6% 1-Year Est. Return
BC
Blackstart Capital New York $151M AUM 14.01% 1-Year Est. Return
JT
Jump Trading Chicago, Illinois $150M AUM 17.61% 1-Year Est. Return
SCM
Stellar Capital Management Phoenix, Arizona $147M AUM 5.91% 1-Year Est. Return
HF
Hellman & Friedman San Francisco, California $169M AUM
SMFS
Squar Milner Financial Services Irvine, California $176M AUM 10.56% 1-Year Est. Return
CCM
Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return
CCM
Castine Capital Management Boston, Massachusetts $129M AUM 23.45% 1-Year Est. Return

Stralem & Co's Q4 2015 Portfolio in Review

As of Q4 2015, Stralem & Co held 60 positions worth $988M, down 18% from $1.2B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Stralem & Co withdrew a net $308M in Q4 2015, closing 5 positions and reducing 36 holdings. Its most notable exit was Warner Bros, an estimated $31.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Consumer Staples and Utilities.

Against the trend, Stralem & Co opened a new position in Intercontinental Exchange worth $30.1M.

  • Stralem & Co's largest Q4 2015 buy was Intercontinental Exchange: 587,200 shares worth $30.1M.
  • Stralem & Co added most to Mondelez International in Q4 2015, an estimated $24.6M increase.
  • Stralem & Co's biggest Q4 2015 reduction was RTX Corp, cutting an estimated $31.8M.
  • Stralem & Co fully exited Warner Bros in Q4 2015, selling an estimated $31.8M.
  • Stralem & Co's ten largest holdings make up 32% of its $988M portfolio in Q4 2015.
  • Stralem & Co opened 5 new positions and closed 5 in Q4 2015.
  • Stralem & Co's portfolio value fell 18% quarter-over-quarter to $988M.

Based on Stralem & Co's 13F filing for Q4 2015, filed 19 Jan 2016.